23rd September 2026
For over 20 years, the CPHI Pharma Awards have recognised the individuals, teams, and companies driving innovation across the pharmaceutical industry. The finalist shortlist for 2026 has now been confirmed, spanning 15 categories that reflect the industry's current priorities: advanced manufacturing, digitalisation, supply chain resilience, sustainability, patient access and industry leadership. Winners will be announced live at CPHI Milan on October 6.
Several categories recognise progress at the scientific and manufacturing core of the industry. API Development & Innovation highlights advances in the synthesis, characterisation, and manufacture of APIs, with this year's finalists spanning peptide synthesis and next-generation antibody-drug conjugate platforms. Finished Formulation recognises innovation in drug product formulation, and this year's shortlist is notable for its concentration of entries addressing bioavailability enhancement for poorly soluble compounds. Manufacturing Excellence, open to both small and large molecule production, includes finalists ranging from advanced tableting technology to next-generation cell and gene therapy manufacturing facilities.

